Scot Niglio, M.D., M.S.
Dr. Niglio is a medical oncologist who specializes in the care of patients with genitourinary cancers (prostate, kidney, bladder, testicular). His research focuses on using a person’s own immune system to fight cancer. He also develops treatments personalized to an individual patient’s cancer based on gene mutations and tumor characteristics.
Dr. Niglio is board certified in internal medicine and medical oncology.
1) genitourinary cancers, 2) bladder cancer, 3) rare genitourinary cancers, 4) immuno-oncology, 5) immunotherapy, 6) personalized medicine
Center for Cancer Research
National Cancer Institute
Building 10, Room 12C342B
Bethesda, MD 20892
Dr. Niglio develops new treatments for genitourinary cancers (bladder, prostate, kidney, and testicular cancers). His research focuses on using a person’s own immune system to fight cancer. He also develops treatments personalized to an individual patient’s cancer based on gene mutations and tumor characteristics.
Selected Key Publications
Programmed Death-1 or Programmed Death Ligand-1 Blockade in Patients with Platinum-resistant Metastatic Urothelial Cancer: A Systematic Review and Meta-analysis.European Urology. Epub ahead of print, 2019. [ Journal Article ]
- JNCI Cancer Spectrum. 2(4): pky075, 2018. [ Journal Article ]
DNA Damage Response as Biomarkers Informing a Precision Medicine Approach to Bladder Cancer: What are the Next Steps?.Expert Review of Precision Medicine and Drug Development. 4: 7-9, 2019.
Effectiveness of Transurethral Resection plus Systemic Chemotherapy as Definitive Treatment for Muscle Invasive Bladder Cancer in Population Level Data.The Journal of Urology. 200(5): 996-1004, 2018. [ Journal Article ]
Precision Medicine for Relapsed Multiple Myeloma on the Basis of an Integrative Multiomics Approach.JCO Precision Oncology. Epub 2018 Aug 8, 2018. [ Journal Article ]
Dr. Scot Niglio graduated from Villanova University with a Bachelor of Science in biology where he was inducted into the Phi Beta Kappa Honor Society and went on to receive a Master of Science in physiology from Georgetown University. He then earned a Master of Science in clinical and translational science at the University of Medicine and Dentistry of New Jersey (now Rutgers University) in combination with his medical degree. He completed his internal medicine residency as well as a hematology and medical oncology fellowship at the Icahn School of Medicine at Mount Sinai. Dr. Niglio has received honors such as the Young Investigator Award (2019) from the Conquer Cancer Foundation (ASCO) and he has been named "40 under 40 in Cancer" (2019) by the Lynx Group. This award recognizes the contributions being made by rising stars and emerging leaders across the field of cancer research under the age of 40.